Madrigal Pharmaceuticals (MDGL) News Today

$204.65
-13.73 (-6.29%)
(As of 04/24/2024 ET)
SourceHeadline
msn.com logoMadrigal Pharmaceuticals to Unveil First-Quarter Results, Hosts Live Webcast
msn.com - April 25 at 1:07 AM
marketbeat.com logoMadrigal Pharmaceuticals (NASDAQ:MDGL) Trading Down 6%
marketbeat.com - April 24 at 7:14 PM
globenewswire.com logoMadrigal Statement on the Passing of Dr. Stephen Harrison
globenewswire.com - April 24 at 4:00 PM
finance.yahoo.com logoMadrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
finance.yahoo.com - April 23 at 8:19 AM
MarketBeat logoMadrigal Pharmaceuticals (NASDAQ:MDGL) Coverage Initiated by Analysts at Bank of America
americanbankingnews.com - April 23 at 3:34 AM
markets.businessinsider.com logoUnited Healthcare’s Favorable Insurance Coverage of Rezdiffra Boosts Madrigal Pharmaceuticals Buy Rating
markets.businessinsider.com - April 22 at 8:53 PM
marketbeat.com logoMadrigal Pharmaceuticals (NASDAQ:MDGL) Earns Underperform Rating from Analysts at Bank of America
marketbeat.com - April 22 at 8:29 AM
marketbeat.com logoKnights of Columbus Asset Advisors LLC Acquires 4,386 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
marketbeat.com - April 21 at 6:39 AM
msn.com logoMadrigal Pharmaceuticals Welcomes New Employees with Equity Awards
msn.com - April 20 at 6:14 AM
marketbeat.com logoMadrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price Down 3.3%
marketbeat.com - April 17 at 12:20 PM
globenewswire.com logoMadrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - April 16 at 4:05 PM
investorplace.com logo7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024
investorplace.com - April 15 at 7:52 AM
marketbeat.com logo211,488 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Purchased by AlpInvest Partners B.V.
marketbeat.com - April 14 at 8:45 PM
insidertrades.com logoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) CMO Rebecca Taub Sells 2,676 Shares
insidertrades.com - April 11 at 6:37 AM
insidertrades.com logoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Paul A. Friedman Sells 26,270 Shares of Stock
insidertrades.com - April 11 at 6:16 AM
msn.com logoMadrigal Pharmaceuticals Launches Rezdiffra, a Pioneer in NASH Treatment
msn.com - April 10 at 10:34 PM
msn.com logo2 Under-the-Radar Growth Stocks to Consider
msn.com - April 10 at 12:33 PM
fool.com logo2 Under-the-Radar Growth Stocks to Consider
fool.com - April 10 at 10:15 AM
marketbeat.com logoMoody Aldrich Partners LLC Sells 4,356 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
marketbeat.com - April 10 at 8:54 AM
finance.yahoo.com logoMadrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
finance.yahoo.com - April 9 at 8:42 AM
insidertrades.com logoJames M. Daly Sells 32,489 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock
insidertrades.com - April 9 at 4:22 AM
cnn.com logoMadrigal Pharmaceuticals, Inc.
cnn.com - April 7 at 1:19 AM
msn.com logoMadrigal Pharmaceuticals Awards Equity to New Employees as Inducement
msn.com - April 6 at 8:18 PM
insidertrades.com logoInsider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells 18,710 Shares of Stock
insidertrades.com - April 6 at 7:30 AM
marketbeat.com logoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Paul A. Friedman Sells 18,710 Shares
marketbeat.com - April 5 at 9:06 PM
fool.com logoBetter Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
fool.com - April 5 at 7:15 AM
finance.yahoo.com logoMadrigal Pharmaceuticals Inc Director Kenneth Bate Sells 32,489 Shares
finance.yahoo.com - April 4 at 8:35 AM
finance.yahoo.com logoMadrigal Pharmaceuticals Inc Director Richard Levy Sells 11,000 Shares
finance.yahoo.com - April 4 at 8:35 AM
finance.yahoo.com logoMadrigal Pharmaceuticals Inc Director James Daly Sells 32,489 Shares
finance.yahoo.com - April 4 at 8:35 AM
insidertrades.com logoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Richard S. Levy Sells 11,000 Shares
insidertrades.com - April 4 at 5:59 AM
globenewswire.com logoMadrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - April 3 at 4:05 PM
fool.com logo1 No-Brainer Growth Stock to Buy Now
fool.com - April 3 at 8:45 AM
seekingalpha.com logoViking Therapeutics: Future Weight Loss Heavyweight?
seekingalpha.com - April 2 at 7:31 AM
marketbeat.com logoAssenagon Asset Management S.A. Cuts Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
marketbeat.com - April 2 at 4:38 AM
investorplace.com logoThe 3 Best Biotech Stocks to Buy in April 2024
investorplace.com - April 1 at 9:09 PM
marketbeat.com logo4,773 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Purchased by AMI Asset Management Corp
marketbeat.com - March 30 at 11:30 PM
fool.com logoBetter Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
fool.com - March 29 at 9:00 AM
fool.com logoIs This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?
fool.com - March 29 at 4:43 AM
marketbeat.com logoMadrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded at StockNews.com
marketbeat.com - March 28 at 11:15 PM
marketbeat.com logo7 Stocks That Will Drive the Weight Loss Drugs Market (MDGL)
marketbeat.com - March 28 at 7:22 AM
fool.com logoHere's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock
fool.com - March 26 at 3:21 PM
marketbeat.com logoAmerican Century Companies Inc. Increases Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
marketbeat.com - March 25 at 4:09 AM
fool.com logoThis Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?
fool.com - March 22 at 6:15 AM
marketbeat.com logoDeutsche Bank AG Acquires 6,840 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
marketbeat.com - March 22 at 4:13 AM
finance.yahoo.com logoMDGL May 2024 390.000 call
finance.yahoo.com - March 20 at 4:27 PM
marketbeat.com logoMadrigal Pharmaceuticals (NASDAQ:MDGL) Trading Down 4.8%
marketbeat.com - March 20 at 12:46 PM
marketbeat.com logoMadrigal Pharmaceuticals (NASDAQ:MDGL) PT Raised to $405.00
marketbeat.com - March 20 at 11:41 AM
marketbeat.com logoStockNews.com Upgrades Madrigal Pharmaceuticals (NASDAQ:MDGL) to "Sell"
marketbeat.com - March 19 at 11:23 PM
finance.yahoo.com logoMDGL May 2024 350.000 call
finance.yahoo.com - March 19 at 10:03 PM
finance.yahoo.com logoMDGL May 2024 230.000 put
finance.yahoo.com - March 19 at 10:03 PM
Get Madrigal Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter.

The system that called 2023’s top 7 stocks is at it again… (Ad)

Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.

Just follow this link here!

MDGL Media Mentions By Week

MDGL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MDGL
News Sentiment

0.56

0.43

Average
Medical
News Sentiment

MDGL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MDGL Articles
This Week

9

5

MDGL Articles
Average Week

Get Madrigal Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MDGL) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners